Stifel Financial
IDYA icon

Stifel Financial’s IDEAYA Biosciences IDYA Stock Holding History

Stifel Financial’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$917K Sell
24,617
-1,098
-4% -$33.6K ﹤0.01% 2611
2026
Q1 		$857K Sell
25,715
-1,624
-6% -$54.5K ﹤0.01% 2542
2025
Q4 		$945K Sell
27,339
-4,495
-14% -$143K ﹤0.01% 2471
2025
Q3 		$866K Buy
31,834
+1,312
+4% +$31.7K ﹤0.01% 2485
2025
Q2 		$642K Buy
30,522
+6,069
+25% +$116K ﹤0.01% 2614
2025
Q1 		$401K Buy
24,453
+751
+3% +$16K ﹤0.01% 2831
2024
Q4 		$609K Sell
23,702
-3,834
-14% -$109K ﹤0.01% 2562
2024
Q3 		$872K Sell
27,536
-1,888
-6% -$71.6K ﹤0.01% 2323
2024
Q2 		$1.03M Buy
29,424
+4,254
+17% +$168K ﹤0.01% 2142
2024
Q1 		$1.1M Buy
+25,170
New +$1.08M ﹤0.01% 2128

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Stifel Financial's IDYA Position: Q2 2026 in Review

Stifel Financial reduced its IDEAYA Biosciences (IDYA) stake by 4.3% in Q2 2026, selling an estimated $33.6K and leaving 24,617 shares worth $917K. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

Stifel Financial first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.1M in Q1 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Stifel Financial held 24,617 shares of IDEAYA Biosciences worth $917K as of Q2 2026.
  • Stifel Financial sold 1,098 IDEAYA Biosciences shares in Q2 2026, an estimated $33.6K.
  • IDEAYA Biosciences made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2611 holding.
  • Stifel Financial first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Stifel Financial's IDEAYA Biosciences position peaked at $1.1M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.